GenMark Diagnostics, Inc (GNMK) SVP Jennifer Anne Williams Sells 5,147 Shares
GenMark Diagnostics, Inc (NASDAQ:GNMK) SVP Jennifer Anne Williams sold 5,147 shares of the firm’s stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $4.40, for a total value of $22,646.80. Following the transaction, the senior vice president now directly owns 149,342 shares of the company’s stock, valued at approximately $657,104.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
GenMark Diagnostics, Inc (NASDAQ:GNMK) traded up $0.07 on Thursday, hitting $4.46. The stock had a trading volume of 152,600 shares, compared to its average volume of 475,470. The company has a current ratio of 2.97, a quick ratio of 2.77 and a debt-to-equity ratio of 0.12. The stock has a market cap of $240.55, a price-to-earnings ratio of -3.66 and a beta of 0.78. GenMark Diagnostics, Inc has a 12-month low of $3.63 and a 12-month high of $13.67.
Several institutional investors and hedge funds have recently bought and sold shares of GNMK. Wrapmanager Inc. raised its position in shares of GenMark Diagnostics by 121.3% in the 4th quarter. Wrapmanager Inc. now owns 39,547 shares of the medical equipment provider’s stock worth $165,000 after purchasing an additional 21,679 shares during the last quarter. UBS Asset Management Americas Inc. increased its holdings in GenMark Diagnostics by 111.1% in the 4th quarter. UBS Asset Management Americas Inc. now owns 49,400 shares of the medical equipment provider’s stock worth $206,000 after buying an additional 26,000 shares in the last quarter. OLD National Bancorp IN increased its holdings in GenMark Diagnostics by 120.6% in the 4th quarter. OLD National Bancorp IN now owns 49,765 shares of the medical equipment provider’s stock worth $208,000 after buying an additional 27,208 shares in the last quarter. Fairpointe Capital LLC bought a new stake in GenMark Diagnostics in the 4th quarter worth about $220,000. Finally, FDx Advisors Inc. increased its holdings in GenMark Diagnostics by 124.1% in the 4th quarter. FDx Advisors Inc. now owns 53,689 shares of the medical equipment provider’s stock worth $224,000 after buying an additional 29,729 shares in the last quarter.
TRADEMARK VIOLATION NOTICE: “GenMark Diagnostics, Inc (GNMK) SVP Jennifer Anne Williams Sells 5,147 Shares” was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://theolympiareport.com/2018/02/22/genmark-diagnostics-inc-gnmk-svp-jennifer-anne-williams-sells-5147-shares.html.
About GenMark Diagnostics
GenMark Diagnostics, Inc is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology.
Receive News & Ratings for GenMark Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GenMark Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.